Synthesis of Osteocalcin in Bone
骨中骨钙素的合成
基本信息
- 批准号:7904360
- 负责人:
- 金额:$ 39.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcetylationAcuteAddressAdultArchitectureBindingBiological AssayBone DensityBone MarrowBoxingC-terminalCalvariaCell LineCellsChromatinChromatin Remodeling FactorComplexDevelopmentDissociationEmbryoEnhancersEnvironmentEpigenetic ProcessEventFibroblastsGene ExpressionGene Expression RegulationGene TargetingGenesGenetic TranscriptionGoalsHistone AcetylationHistone CodeHistone H3Homeodomain ProteinsHumanIn VitroInvestigationKnockout MiceLong-Term EffectsLysineMediatingMethylationModificationMolecularMusMutationNull LymphocytesOsteoblastsOsteocalcinOsteogenesisPathway interactionsPatientsPatternPhenotypePropertyProteinsRattusRegulationRegulatory ElementRegulatory PathwayReporterRepressionRoleSiteSkeletonSmall Interfering RNAStagingStromal CellsTestingTimeTissuesTranscription CoactivatorTranscriptional RegulationWorkbasebonebone qualitychromatin modificationchromatin remodelinggenetic regulatory proteinhistone modificationhomeodomainin vivoinsightloss of functionmineralizationmutantnovelnull mutationosteoblast differentiationosteogenicosteoprogenitor cellprogramspromoterprotein protein interactionsmall hairpin RNAstable cell linetranscription factor
项目摘要
DESCRIPTION (provided by applicant): This program continues to study the tissue specific and developmental regulation of the osteocalcin (OC) gene and the factors that contribute to induction and progression of osteoblast (OB) maturation. In the current program period, we discovered a regulatory network of homeodomain (HD) proteins that provide molecular switches for mediating the temporal expression of OC with a pivotal activating role for Dlx3 at the onset of OC transcription. A novel regulatory element for the Hox transcription factors was discovered that binds Hoxa10 for activation of OC transcription. Hoxa10 and Dlx3 are bound to the OC gene prior to Runx2 and increase again with Runx2 binding. In addition, these factors can activate the OC gene in Runx2 null cells, thus providing evidence for molecular events contributing to expression of the OC and bone related genes upstream of Runx2. These findings justify further investigation of their functional roles in osteoblasts in vivo and in vitro. We postulate that these two regulatory factors have key roles in regulating gene expression throughout OB differentiation, a function distinct from their activities in embryonic patterning of the skeleton. We will identify these OB- related functions by determining the mechanism by which they regulate developmental expression of OC which include contributing to chromatin remodeling, regulating activation and repression of gene transcription through interactions with co-regulatory factors, and functioning both independent of Runx2 and coordinated with Runx2 for establishment of the OB phenotype. Aim1 tests the hypothesis that dynamic association/dissociation of these factors with osteocalcin chromatin occurs at specific stages of phenotype development due to formation of transcription factor complexes modifying chromatin architecture of OC. Aim 2 addresses the hypothesis that Hoxa10 functions upstream of Runx2 to promote epigenetic marking of the OC gene for tissue specific activation, and regulation of target gene expression in OBs. Its deletion from OB in vitro and in vivo is postulated to alter OB maturation and contribute to a mild bone phenotype in adult mice. Aim 3 postulates that Dlx3 has a transient role in gene regulation, responsible for the timing of transcription of the OC gene and coordinated occupancy of Runx2 which will be addressed ex vivo in cells from the Dlx3 null and conditional knockout mice. We further postulate that the human Dlx3 tricho-dento-osseous (TDO) mutation alters the transient function of Dlx3 in osteoblasts as a result of loss-of-function of interacting co-regulatory proteins. These studies will identify novel mechanisms and regulatory pathways required for induction and regulation of OC and regulation of OB maturation to the differentiated phenotype in a mineralizing matrix.PROJECT NARRATIVE
描述(由申请人提供):该项目继续研究骨钙素(OC)基因的组织特异性和发育调节以及促进成骨细胞(OB)成熟诱导和进展的因素。在目前的计划期间,我们发现了一个同源域(HD)蛋白的调节网络,提供分子开关,用于介导OC的时间表达,在OC转录开始时,Dlx 3具有关键的激活作用。Hox转录因子的一个新的调控元件被发现,结合Hoxa 10激活OC转录。Hoxa 10和Dlx 3在Runx 2之前与OC基因结合,并在Runx 2结合时再次增加。此外,这些因子可以激活Runx 2无效细胞中的OC基因,从而为促进Runx 2上游OC和骨相关基因表达的分子事件提供证据。这些发现证明了进一步研究其在体内和体外成骨细胞中的功能作用。我们推测,这两个调节因子在调节整个OB分化的基因表达中具有关键作用,这一功能不同于它们在胚胎骨骼模式中的活动。我们将通过确定这些OB相关功能调节OC发育表达的机制来鉴定这些功能,包括促进染色质重塑,通过与共调节因子的相互作用调节基因转录的激活和抑制,以及独立于Runx 2并与Runx 2协调以建立OB表型。目的1测试的假设,动态协会/解离这些因素与骨钙蛋白染色质发生在特定阶段的表型发展,由于形成转录因子复合物修改染色质结构的OC。目的2地址的假设,Hoxa 10的功能上游Runx 2促进表观遗传标记的OC基因的组织特异性激活,并在OBs的靶基因表达的调节。其从OB在体外和体内的缺失被假定为改变OB成熟,并有助于一个温和的骨表型在成年小鼠。目的3假设Dlx 3在基因调控中具有瞬时作用,负责OC基因的转录时间和Runx 2的协调占据,这将在来自Dlx 3缺失和条件性敲除小鼠的细胞中离体解决。我们进一步假设,人类Dlx 3牙-牙-骨(TDO)突变改变了Dlx 3在成骨细胞中的瞬时功能,这是相互作用的共调节蛋白功能丧失的结果。这些研究将确定新的机制和调控途径所需的诱导和调节OC和调节OB成熟的分化表型在矿化基质。项目叙述
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jane B. Lian其他文献
Networks and hubs for the transcriptional control of osteoblastogenesis
- DOI:
10.1007/s11154-006-9001-5 - 发表时间:
2006-06-01 - 期刊:
- 影响因子:8.000
- 作者:
Jane B. Lian;Gary S. Stein;Amjad Javed;Andre J. van Wijnen;Janet L. Stein;Martin Montecino;Mohammad Q. Hassan;Tripti Gaur;Christopher J. Lengner;Daniel W. Young - 通讯作者:
Daniel W. Young
Gamma-carboxyglutamate excretion and calcinosis in juvenile dermatomyositis.
幼年皮肌炎中的γ-羧基谷氨酸排泄和钙质沉着。
- DOI:
10.1002/art.1780250910 - 发表时间:
1982 - 期刊:
- 影响因子:0
- 作者:
Jane B. Lian;Jane B. Lian;Lauren M. Pachman;C. Gundberg;Raymond E. H. Partridge;M. Maryjowski - 通讯作者:
M. Maryjowski
LB-036 - Cbfβ prevents articular cartilage degeneration
- DOI:
10.1016/j.joca.2024.03.038 - 发表时间:
2024-06-01 - 期刊:
- 影响因子:
- 作者:
Xiangguo Che;Xian Jin;Dong-Kyo Lee;Hee-June Kim;Hee-Soo Kyung;Hyun-Ju Kim;Jane B. Lian;Janet L. Stein;Gary S. Stein;Je-Yong Choi - 通讯作者:
Je-Yong Choi
Mitotic bookmarking of genes: a novel dimension to epigenetic control
基因的有丝分裂书签:表观遗传控制的一个新维度
- DOI:
10.1038/nrg2827 - 发表时间:
2010-07-13 - 期刊:
- 影响因子:52.000
- 作者:
Sayyed K. Zaidi;Daniel W. Young;Martin A. Montecino;Jane B. Lian;Andre J. van Wijnen;Janet L. Stein;Gary S. Stein - 通讯作者:
Gary S. Stein
Nuclear microenvironments in biological control and cancer
生物防治和癌症中的核微环境
- DOI:
10.1038/nrc2149 - 发表时间:
2007-06-01 - 期刊:
- 影响因子:66.800
- 作者:
Sayyed K. Zaidi;Daniel W. Young;Amjad Javed;Jitesh Pratap;Martin Montecino;Andre van Wijnen;Jane B. Lian;Janet L. Stein;Gary S. Stein - 通讯作者:
Gary S. Stein
Jane B. Lian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jane B. Lian', 18)}}的其他基金
Project 3: MANCR Mediates Epigenetic Mechanisms for Survival of Advanced Breast Cancer
项目 3:MANCR 介导晚期乳腺癌生存的表观遗传机制
- 批准号:
10380073 - 财政年份:2021
- 资助金额:
$ 39.11万 - 项目类别:
Project 3: MANCR Mediates Epigenetic Mechanisms for Survival of Advanced Breast Cancer
项目 3:MANCR 介导晚期乳腺癌生存的表观遗传机制
- 批准号:
10608059 - 财政年份:2021
- 资助金额:
$ 39.11万 - 项目类别:
Runx2 Organizes Transcriptional Complexes in Nuclear Microenvironments to Support
Runx2 在核微环境中组织转录复合物以支持
- 批准号:
8601049 - 财政年份:2013
- 资助金额:
$ 39.11万 - 项目类别:
Runx2 Organizes Transcriptional Complexes in Nuclear Microenvironments to Support
Runx2 在核微环境中组织转录复合物以支持
- 批准号:
8052327 - 财政年份:2011
- 资助金额:
$ 39.11万 - 项目类别:
RUNX@ Subnuclear Targeting Integrates Signaling Pathways for Bone Formation
RUNX@ 亚核靶向整合骨形成信号通路
- 批准号:
8289359 - 财政年份:2011
- 资助金额:
$ 39.11万 - 项目类别:
相似海外基金
Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
- 批准号:
EP/Y000331/1 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
- 批准号:
10677295 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
- 批准号:
10635599 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
- 批准号:
10752320 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
- 批准号:
478927 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
- 批准号:
10855703 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
- 批准号:
10654210 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
- 批准号:
10726986 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:














{{item.name}}会员




